Bethany Hannafon to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications Bethany Hannafon has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.870
-
Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ. Am J Pathol. 2019 05; 189(5):966-974.
Score: 0.504
-
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study. BMC Cancer. 2019 Jun 28; 19(1):642.
Score: 0.133
-
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer. 2015 Jul 16; 14:133.
Score: 0.101
-
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res. 2011 Mar 04; 13(2):R24.
Score: 0.075
-
Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1) degradation. J Nutr Biochem. 2014 May; 25(5):515-25.
Score: 0.023
-
Clofibrate induces heme oxygenase 1 expression through a PPARa-independent mechanism in human cancer cells. Cell Physiol Biochem. 2013; 32(5):1255-64.
Score: 0.022
-
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Invest New Drugs. 2005 Oct; 23(5):417-28.
Score: 0.013